[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA03007332A - Composiciones de levotiroxina y metodos para elaborar la misma. - Google Patents

Composiciones de levotiroxina y metodos para elaborar la misma.

Info

Publication number
MXPA03007332A
MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A
Authority
MX
Mexico
Prior art keywords
methods
compositions
sodium
making
levothyroxine
Prior art date
Application number
MXPA03007332A
Other languages
English (en)
Inventor
A Dimenna Philip
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Priority claimed from PCT/US2002/004665 external-priority patent/WO2003070217A1/en
Publication of MXPA03007332A publication Critical patent/MXPA03007332A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere generalmente a composiciones farmaceuticas estables y metodos para la elaboracion y administracion de tales composiciones. En un aspecto, la invencion caracteriza composiciones farmaceuticas estabilizadas que incluyen ingredientes farmaceuticamente activos tales como la levotiroxina sodio (T4) y liotironina sodio (T3) (farmacos de hormonas tiroides), preferiblemente en una forma de dosis solida de liberacion inmediata. Tambien se proporcionan metodos para la elaboracion y uso de tales composiciones estabilizadas y de liberacion inmediata.
MXPA03007332A 2001-02-15 2002-02-15 Composiciones de levotiroxina y metodos para elaborar la misma. MXPA03007332A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26899801P 2001-02-15 2001-02-15
US26900901P 2001-02-15 2001-02-15
PCT/US2002/004665 WO2003070217A1 (en) 2002-02-15 2002-02-15 Levothyroxine compositions and methods

Publications (1)

Publication Number Publication Date
MXPA03007332A true MXPA03007332A (es) 2005-11-10

Family

ID=28044645

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007332A MXPA03007332A (es) 2001-02-15 2002-02-15 Composiciones de levotiroxina y metodos para elaborar la misma.

Country Status (4)

Country Link
AU (1) AU2002240394A1 (es)
BR (1) BR0207299A (es)
MX (1) MXPA03007332A (es)
NO (1) NO20033636L (es)

Also Published As

Publication number Publication date
AU2002240394A1 (en) 2003-09-09
BR0207299A (pt) 2005-02-09
NO20033636D0 (no) 2003-08-15
NO20033636L (no) 2003-10-15

Similar Documents

Publication Publication Date Title
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
PT1412384E (pt) Formulação estável de glp-1 modificado
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
AP2001002264A0 (en) Sustained release formulations for growth hormone secretagogues.
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
AU7315301A (en) Compounds and compositions for delivering active agents
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
TW200633730A (en) Oral disintegrating dosage forms
GEP20053473B (en) High Potency Dihydroergotamine Compositions
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
WO2003028624A3 (en) Levothyroxine compositions and methods
IL150528A0 (en) Ibuprofen containing active agent preparation
AP2003002763A0 (en) Controlled release formulations for oral administration
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
CY1107295T1 (el) Σταθεροποιηση στερεων φορμουλων φαρμακων του θυρεοειδους
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2003013441A3 (en) Levothyroxine compositions and methods
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
WO2004014318A3 (en) Levothyroxine compositions and methods
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy